Eminence Capital LP Makes New $179.52 Million Investment in UnitedHealth Group Incorporated $UNH

Eminence Capital LP bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 575,451 shares of the healthcare conglomerate’s stock, valued at approximately $179,523,000. UnitedHealth Group makes up approximately 2.2% of Eminence Capital LP’s portfolio, making the stock its 18th biggest holding. Eminence Capital LP owned 0.06% of UnitedHealth Group at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Engineers Gate Manager LP increased its holdings in shares of UnitedHealth Group by 6.0% in the 2nd quarter. Engineers Gate Manager LP now owns 26,305 shares of the healthcare conglomerate’s stock valued at $8,206,000 after acquiring an additional 1,487 shares during the last quarter. BBR Partners LLC boosted its stake in UnitedHealth Group by 14.3% in the second quarter. BBR Partners LLC now owns 888 shares of the healthcare conglomerate’s stock valued at $277,000 after acquiring an additional 111 shares in the last quarter. Berkshire Hathaway Inc acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $1,572,193,000. Boone Capital Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $18,129,000. Finally, Braidwell LP acquired a new position in UnitedHealth Group during the second quarter worth approximately $15,411,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH opened at $341.83 on Friday. The company has a market capitalization of $309.65 billion, a PE ratio of 17.84, a P/E/G ratio of 2.20 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a 50-day simple moving average of $339.84 and a 200-day simple moving average of $316.91. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company posted $7.15 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Barclays lifted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Bank of America lifted their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday, October 28th. Seventeen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.